Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer
- DOI
- 10.1038/s41598-026-60339-7
- Published
- 2026-08-13
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-60339-7,
title = {Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer},
author = {Anisha Jain and Chandan Dharmashekar and Bhargav Shreevatsa K S and Kavitha Raj and Amogha Shivakumar and Shiva Prasad Kollur and Chandan Shivamallu and Ashwini Prasad and M. N. Nagendra Prasad},
year = {2026},
journal = {Scientific Reports},
doi = {10.1038/s41598-026-60339-7},
url = {https://doi.org/10.1038/s41598-026-60339-7}
}RIS
TY - JOUR TI - Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer AU - Anisha Jain AU - Chandan Dharmashekar AU - Bhargav Shreevatsa K S AU - Kavitha Raj AU - Amogha Shivakumar AU - Shiva Prasad Kollur AU - Chandan Shivamallu AU - Ashwini Prasad AU - M. N. Nagendra Prasad PY - 2026 JO - Scientific Reports DO - 10.1038/s41598-026-60339-7 UR - https://doi.org/10.1038/s41598-026-60339-7 ER -
APA
Jain, A., Dharmashekar, C., S, B. S. K., Raj, K., Shivakumar, A., Kollur, S. P., Shivamallu, C., Prasad, A., & Prasad, M. N. N. (2026). Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer. Scientific Reports. https://doi.org/10.1038/s41598-026-60339-7
Source records
- crossref · retrieved 2026-09-25T13:16:13.739Z